How Sglt-2 Inhibitors Improve Glycemic Control in Type 2 Diabetes

in mrmed •  last year 

Chronic metabolic disease known as type 2 diabetes mellitus (T2DM) is characterised by elevated blood sugar levels and insulin resistance. The development of sodium-glucose cotransporter-2 (SGLT-2) inhibitors is one important development in the treatment of T2DM that has occurred throughout the years. Dapagliflozin-containing Forxiga 10 was created to treat diabetes and has completely changed how glycemic management is approached.

mrmed mrmedpharmacy diabetes type2diabetes sglt2inhibitors forxiga10mg
last year by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!